Biogen | Activos Circulantes



Current Assets Cambio Fecha
AbbVie USD 27.68B 2.09B 2025-03
Acadia Pharmaceuticals USD 960.55M 89.61M 2025-06
ALKERMES USD 1.64B 156.24M 2025-06
Amgen USD 26.73B 195M 2025-06
Bayer EUR 33.75B 1.08B 2025-06
Biogen USD 7.97B 341.7M 2025-06
BioMarin Pharmaceutical USD 3.81B 337.43M 2025-06
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Eli Lilly USD 49.85B 8.59B 2025-06
Gilead Sciences USD 14.72B 2.18B 2025-06
Incyte USD 3.64B 411.91M 2025-06
Merck USD 37.07B 1.56B 2025-06
Moderna USD 6.17B 595M 2025-06
Neurocrine Biosciences USD 1.75B 111M 2025-06
Novartis USD 25.94B 831M 2025-06
Pfizer USD 43.7B 2.16B 2025-06
PTC Therapeutics USD 2.27B 43.53M 2025-06
Regeneron Pharmaceuticals USD 16.86B 712.2M 2025-06
Sanofi 37.02B 7B 2025-06
Sanofi 42.59B 12.51B 2024-12
Sarepta Therapeutics USD 2.66B 224.45M 2025-06
Teva Pharmaceutical Industries USD 12.62B 1.09B 2025-06
Ultragenyx Pharmaceutical USD 719.79M 20.63M 2025-06
United Therapeutics USD 3.83B 112.9M 2025-06
Vertex Pharmaceuticals USD 10.43B 419.1M 2025-06


Biogen Activos Circulantes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.